US FDA Approves Ocrelizumab (Ocrevus) MStranslate March 30, 2017 Ocrelizumab, Treatments Ocrelizumab (Ocrevus) has been granted US FDA approval for the treatment of both replacing-remitting MS (RRMS) and primary progressive MS (PPMS). Ocrelizumab is a monoclonal antibody that targets and...
